Vera Therapeutics, Inc
VERA
NASDAQ
Biotechnology
$31.63
USD
+2.74 (+9.48%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.16B
Volume 5.9M
Price Target
$90.00 – $90.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $90.00 and a min estimate of $90.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$90.00
-$6.3 vs prior
Implied Upside
+184.5%
-20.0% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Arthur He | HC Wainwright & Co. | Buy | Maintained | 3 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SLS
Sellas Life Sciences Group Inc
$12.78
▲ +3.4%
BCRX
BioCryst Pharmaceuticals Inc
$9.74
▼ -0.7%
PVLA
Palvella Therapeutics Inc
$156.13
▼ -0.3%
CDNA
CareDx Inc
$45.32
▼ -4.3%
VCEL
Vericel Corp
$44.20
▼ -0.8%
COAG
Hemab Therapeutics Holdings Inc
$54.94
▲ +1.8%
MLYS
Mineralys Therapeutics Inc
$25.64
▼ -1.7%
KLRA
Kailera Therapeutics Inc
$17.94
▼ -0.2%